Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsPomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaEvaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerPemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerVinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerFulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerCollection of Patient-Reported Symptoms and Performance Status Via the InternetNausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung CancerAssessing Older Patients With CancerCitalopram in Treating Postmenopausal Women With Hot FlashesVitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for CancerTopical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for CancerCalcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination ChemotherapyBrostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerCombination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerProbiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation TherapyCombination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell LymphomaStudying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaDasatinib in Treating Patients With Previously Treated Malignant MesotheliomaDasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementBevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver CancerChemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerAcute Pain Caused by Paclitaxel in Patients With CancerIncreasing Patients' Engagement in Breast Cancer Surgery Decision-MakingQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerCapecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal CancerBevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerRadiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung CancerDocetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerBortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionZoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerSurgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung CancerLiposomal SN-38 in Treating Patients With Small Cell Lung CancerSentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung CancerDocetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerFludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaChemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
P859
Q61864694-57DD2AF6-9B5C-44A2-94C4-3688D618C312Q61864779-3B7AA619-C485-4EA9-97F9-38DB3E1F2E8DQ61906994-60B4F4E8-5200-4A78-94AA-D2775D831936Q61918146-BDB4FE0A-3611-46FB-BCA6-EEB7E1C225F2Q61920734-07F0F0BF-5658-4C76-B836-1888D3FC679AQ61921064-EB612328-6735-4F44-B78E-34E2FCFE4333Q61921646-9431CD11-8DDC-473F-9A3F-75268E709AB8Q61922328-FF0A3902-0D49-4C98-B6E4-4D9CC87BB563Q61922369-387999D6-B9BE-482A-AAF2-3ED9CE06B011Q61922390-70CBDCD0-40C7-4F18-8308-F42AE352A9E3Q61934602-6EF33094-29E8-4D30-90CF-D15E36E098C6Q61934734-7D8660B7-C413-49C0-856C-9543066CC3BAQ61934755-FF7614EE-5C8B-4A27-9F1A-54C6FFB5FFB6Q61936210-7A1B528A-F968-4DAE-A670-B810AFEDE2DEQ61937080-B8AF98F8-531B-4C2B-B88B-DF1A1DFEB8FCQ61955362-4AE91826-4FFE-4792-ACB4-1C1B1D6CB79FQ61955363-760FF802-75FB-4FBA-A90C-D00EC9FEA898Q61956013-5E5F3D13-175F-4051-A3E2-92B9462CBE76Q61957393-F8FAC317-B7AC-47F1-A36D-E4D87E86F0FCQ61978936-2FF00229-73CD-43C8-9EF2-D0ABEF86BEE5Q61979494-EB840817-7F8A-41CA-9F5C-FF3C514E4346Q61980727-081FB594-69F6-4060-8F90-39CDDE491038Q61980743-432BD671-1580-45F9-9440-3AE43524A16CQ61980906-A110AF75-2606-41B3-808B-0AD86A78F878Q61981237-6297CE47-D5E6-49B3-8347-2DA0C204D1D0Q61981551-B10F64AA-FEBA-4472-8F10-3C123FBFBBCEQ62031749-B90C73A8-E4A0-4543-A286-5622737899C8Q62104750-C0184464-B59C-4C17-88D7-0EB94A0C5953Q62104881-636DC489-E335-48EB-A472-882B3BBE2CE0Q62105042-F7392AE1-8055-4E9D-8110-DFACEE9242B0Q62105319-F161C502-6ED9-47EE-9C0A-CC3D242D01DBQ62105614-395284D9-902A-4E75-AD2D-867E28BA3348Q62105629-17662744-224F-4D0B-BE47-2A0699A661D7Q62105633-AE320092-E581-4B14-BD6A-16D20BDA858EQ62105639-43A1E51E-B0DA-4056-A27E-A304DCC1F86EQ62105841-1BFCA937-08F1-4CF4-9BD7-D7B81A5C25F2Q62110073-41C52CFF-7D4B-4E52-962E-4FDB060FD3F8Q62110099-5F973CC2-1021-4B77-A83E-6014D1A8356FQ62110203-5C4E2637-AC68-4EE6-A7D8-DDFA61C750F0Q62110273-3BB58EBF-24E5-42D0-A5B3-D7352D3DE56D
P859
name
Alliance for Clinical Trials in Oncology
@en
type
label
Alliance for Clinical Trials in Oncology
@en
prefLabel
Alliance for Clinical Trials in Oncology
@en
P214
P244
P3153
P6366
P131
P213
0000 0001 0279 1086
P214
P2427
grid.468206.e
P244
n2015182752
P3153
P3500
P6366
2799844796
P6782
P7859
lccn-n2015182752